
AcelaBio is a state-of-the-art contract research organization providing end-to-end histopathology and precision medicine laboratory services for pharmaceutical, biotech, and academic institutions. Their services accelerate biomarker discovery and development through advanced capabilities like spatial transcriptomics and digital pathology. AcelaBio is CAP-accredited, ensuring rigorous quality standards and patient safety. They offer wet lab services including H&E staining, special stains, and immunostaining, complemented by dry lab services such as whole slide imaging, digital image analysis using AI, and bioinformatics. Their business model is service-based, supporting global clinical trials and enabling in-depth tissue analysis from sample to score, turning tissue samples into actionable insights.

AcelaBio is a state-of-the-art contract research organization providing end-to-end histopathology and precision medicine laboratory services for pharmaceutical, biotech, and academic institutions. Their services accelerate biomarker discovery and development through advanced capabilities like spatial transcriptomics and digital pathology. AcelaBio is CAP-accredited, ensuring rigorous quality standards and patient safety. They offer wet lab services including H&E staining, special stains, and immunostaining, complemented by dry lab services such as whole slide imaging, digital image analysis using AI, and bioinformatics. Their business model is service-based, supporting global clinical trials and enabling in-depth tissue analysis from sample to score, turning tissue samples into actionable insights.